Actinic Cheilitis
Article Sidebar
Main Article Content
Abstract
Actinic Cheilitis (AC) is one of oral potentially malignant disorders, results from long-term or excessive exposure to the ultraviolet component of solar radiation. The lesion of this patient began with dry scaled vermillion border of lower lip. After peeling off the lesion appears to be easily bleeding-raw surface then form crust before peeling off again. The lesion has been persisted for months, refractory to treatment of 0.1% fluocinolone acetonide in orabase. therefore a choice of CO2 laser was recommended. The patient was ready and willing to take this alternative treatment.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Naville B, Damm D, Allen C, Bouquot J; Oral and Maxillofacial Pathology. 2nd ed.St.Luise: Sounders Elsevier; 2006.
ภัทรนฤน กาญจนบุษย์. ลิวโคเพลเกียและอีริโทรเพลเกีย (Leukoplakia and erythroplakia). ใน: กอบกาญจน์ทองประสม, บรรณาธิการ. การรักษารอยโรคในช่องปากที่พบบ่อย. กรุงเทพฯ : จุฬาลงกรณ์มหาวิทยาลัย; หน้า 55-74.
Isaac van der waal. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45(4-5):317-23.
Angeles Florez, Ana Batalla, Carlos de la Torre. Management of actinic chilitis using ingenol mebutate gel, A report of 7 cases. Journal of Dermatological treatment 2017; 28 (Issue 2) Pages 149-51.
Tzika E, MasouyéI, Mühlstädt M, Laffitte E.Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis 2016 Dermatology. 2016; 232 (Suppl 1): 1-3.
S.H. Choi,K.H.Kim and K.H.Song.Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic chilitis: 12- month follow up results of a prospective, randomized, comparative trial. BJD 2015; 173 (1): 184-91.
Fai D, Romanello E, Brumana MB, Fai C, Vena GA, Cassano N, Piaserico S. Daylight photodynamic therapy with methyl-aminolevulinate for the treatment of actinic cheilitis. Dermatol Ther. 2015 Nov-Dec; 28(6): 355-68.